ETFs compared
Costs, returns, risk and composition side by side, plus how much the holdings overlap.
Performance
- Amundi Core Stoxx Europe 600 UCITS ETF Acc
- Amundi Core Stoxx Europe 600 UCITS ETF EUR Hedged Dist
- iShares STOXX Europe 600 UCITS ETF (DE)
- Xtrackers Stoxx Europe 600 UCITS ETF 2C EUR Hedged
From 18 November 2021. With distributions reinvested.
Key figures
| LYP6.DEAmundi Core Stoxx Europe 600 UCITS ETF Acc | STXH.DEAmundi Core Stoxx Europe 600 UCITS ETF EUR Hedged Dist | EXSA.DEiShares STOXX Europe 600 UCITS ETF (DE) | XSXE.DEXtrackers Stoxx Europe 600 UCITS ETF 2C EUR Hedged | |
|---|---|---|---|---|
| Costs and fund | ||||
| Costs (TER) | 0.07% | 0.15% | 0.20% | 0.25% |
| Costs per year on €10,000 | €7.00 | €15.00 | €20.00 | €25.00 |
| Fund size | €23.19B | €23.19B | €9.78B | €5.99B |
| Holdings | 600 | 600 | 600 | 600 |
| Top 10 share | 19.7% | 19.9% | 19.8% | 19.8% |
| Distribution policy | Accumulating | Distributing, EUR hedged | Distributing | Accumulating, EUR hedged |
| Provider | Amundi | Amundi | iShares | Xtrackers |
| Replication | Physical | Physical | Physical | Physical |
| Domicile | Luxembourg | Luxembourg | Germany | Luxembourg |
| Launched | no data | Apr 2017 | Feb 2004 | Jan 2009 |
| Score and risk | ||||
| Holdings score | 70 | 70 | 70 | 70 |
| Crash risk | 3% | 2% | 3% | 3% |
| Largest drop in 10 years | −35.5% | −33.4% | −35.7% | −35.5% |
| Volatility 1 year | 13.0% | 12.8% | 13.0% | 12.8% |
| Returns | ||||
| Return 1 year | +16.9% | +15.4% | +16.4% | +15.2% |
| 3 years p.a. | +17.7% | +16.9% | +17.6% | +16.8% |
| 5 years p.a. | +9.5% | +8.9% | +9.4% | +8.9% |
| 10 years p.a. | +10.1% | no data | +9.9% | no data |
Green marks the best value in each row. Crash risk counts how often the ETF fell by 30% or more within 12 months over the last ten years, with distributions reinvested. If its history is shorter, the longest history of an ETF on the same index counts, or failing that, the same fund on another exchange in the same currency.
Countries
| LYP6 | STXH | EXSA | XSXE | |
|---|---|---|---|---|
| United Kingdom | 22.0% | 21.9% | 22.0% | 22.0% |
| Switzerland | 15.2% | 15.3% | 15.3% | 14.3% |
| France | 13.3% | 13.3% | 13.5% | 12.4% |
| Germany | 13.1% | 13.2% | 13.2% | 13.2% |
| Netherlands | 8.6% | 8.4% | 8.2% | 9.4% |
| Spain | 5.6% | 5.6% | 5.7% | 6.0% |
| Sweden | 5.3% | 5.3% | 5.2% | 5.3% |
| Italy | 4.8% | 4.9% | 4.9% | 5.2% |
| Denmark | 2.7% | 2.8% | 2.8% | 2.6% |
| Belgium | 1.6% | 1.6% | 1.6% | 1.5% |
Sectors
| LYP6 | STXH | EXSA | XSXE | |
|---|---|---|---|---|
| Financial Services | 25.0% | 25.0% | 24.7% | 26.0% |
| Industrials | 18.7% | 18.7% | 18.3% | 19.4% |
| Healthcare | 13.7% | 13.7% | 13.6% | 12.2% |
| Technology | 8.7% | 8.7% | 8.2% | 9.7% |
| Consumer Defensive | 8.1% | 8.1% | 8.6% | 7.3% |
| Consumer Cyclical | 6.6% | 6.6% | 6.6% | 6.5% |
| Energy | 5.9% | 5.9% | 5.8% | 5.7% |
| Basic Materials | 5.0% | 5.0% | 5.5% | 5.1% |
| Utilities | 4.6% | 4.6% | 4.8% | 4.4% |
| Communication Services | 2.8% | 2.8% | 2.8% | 2.8% |
Holdings overlap
For every common holding the smaller of the two weights counts. 100% would mean identical content, 0% nothing in common.
LYP6.DEandSTXH.DE
97%
97.3% invested alike, 600 holdings in common
| Largest common holdings | LYP6 | STXH |
|---|---|---|
| ASML Holding N.V. | 3.55% | 3.79% |
| Roche Holding AG | 2.20% | 2.21% |
| Novartis AG | 2.03% | 2.02% |
| HSBC HOLDINGS PLC | 1.97% | 1.98% |
| AstraZeneca PLC | 1.91% | 1.90% |
LYP6.DEandEXSA.DE
97%
96.6% invested alike, 594 holdings in common
| Largest common holdings | LYP6 | EXSA |
|---|---|---|
| ASML Holding N.V. | 3.55% | 3.69% |
| Roche Holding AG | 2.20% | 2.22% |
| Novartis AG | 2.03% | 2.04% |
| HSBC HOLDINGS PLC | 1.97% | 1.98% |
| AstraZeneca PLC | 1.91% | 1.92% |
LYP6.DEandXSXE.DE
94%
93.9% invested alike, 583 holdings in common
| Largest common holdings | LYP6 | XSXE |
|---|---|---|
| ASML Holding N.V. | 3.55% | 3.69% |
| Roche Holding AG | 2.20% | 2.22% |
| Novartis AG | 2.03% | 2.04% |
| HSBC HOLDINGS PLC | 1.97% | 1.99% |
| AstraZeneca PLC | 1.91% | 1.92% |
STXH.DEandEXSA.DE
96%
96.5% invested alike, 594 holdings in common
| Largest common holdings | STXH | EXSA |
|---|---|---|
| ASML Holding N.V. | 3.79% | 3.69% |
| Roche Holding AG | 2.21% | 2.22% |
| Novartis AG | 2.02% | 2.04% |
| HSBC HOLDINGS PLC | 1.98% | 1.98% |
| AstraZeneca PLC | 1.90% | 1.92% |
STXH.DEandXSXE.DE
94%
93.7% invested alike, 583 holdings in common
| Largest common holdings | STXH | XSXE |
|---|---|---|
| ASML Holding N.V. | 3.79% | 3.69% |
| Roche Holding AG | 2.21% | 2.22% |
| Novartis AG | 2.02% | 2.04% |
| HSBC HOLDINGS PLC | 1.98% | 1.99% |
| AstraZeneca PLC | 1.90% | 1.92% |
EXSA.DEandXSXE.DE
95%
95.0% invested alike, 588 holdings in common
| Largest common holdings | EXSA | XSXE |
|---|---|---|
| ASML Holding N.V. | 3.69% | 3.69% |
| Roche Holding AG | 2.22% | 2.22% |
| Novartis AG | 2.04% | 2.04% |
| HSBC HOLDINGS PLC | 1.98% | 1.99% |
| AstraZeneca PLC | 1.92% | 1.92% |
Returns with distributions reinvested, in the trading currency; the price chart shows the traded price. Master data and holdings from FMP. Not investment advice.